C. R. Bard, Inc. http://www.alacrastore.com/company-snapshot/C_R_Bard_Inc-1001794 Friday, July 18, 2008 11:05:32 PM 1001794 C. R. Bard, Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/BW-0001-26705472newstex/BW-0001-26705472xml Jul. ##, #### (Business Wire) -- C. R. Bard, Inc. (NYSE: BCR) today announced that it will host a conference call on Wednesday, July ##, #### at #:## PM EDT, to discuss the companya€™s operating results for the second quarter ####,...040000000401600004016048040160187/16/2008 12:08:37 PM180000001800400018008000Business WireBW-0001-26705472BARD C R INCMICROSOFT CORPBCRMSFTNewsNewstexhttp://www.alacrastore.com/storecontent/moodys/PR_156389_600019916moodys/PR_156389_600019916htmlGlobal Credit Research Rating Action ## MAY #### Rating Action: C.R. Bard, Inc. Moody's puts Bard's Baa# rating on review for possible upgrade Affirms Prime-# rating New York, May ##, #### -- Moody's Investors Service placed C.R. Bard,...5/31/2008 1:41:36 AMhtmlC.R. Bard, Inc.C.R. Bard, Inc.600019916150.0000NewsRating ActionPR_156389_600019916Credit & Investment ResearchMoody's Global Credit Researchhttp://www.alacrastore.com/storecontent/newstex/MW-0001-25290702newstex/MW-0001-25290702xml LONDON, UNITED KINGDOM, May ##, #### (Marketwire delivered by Newstex) -- Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. World Urological Catheters...1600000016003000040000000401800013000000130040001300400104007000040070030400600004006005040160000401601304002000040020065/15/2008 6:07:08 AM180000001802000018022000180150001801600019000000190010001900200019002009190020041900201319002007190020121900201019002011MarketwireMW-0001-25290702BARD C R INCBOSTON SCIENTIFIC CORPROCHESTER MEDICAL CORPORATIONBCRBSXROCMNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-25037272newstex/BW-0001-25037272xml BOSTON, May #, #### (Business Wire) -- NMT Medical, Inc. (NASDAQ: NMTI), an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists...070000000700500013000000130100000400000004016000040160480401600104016018040020000400200607014000070140095/6/2008 9:14:50 AM1800000018008000180040001802000019000000190010001900200019002007Business WireBW-0001-25037272BARD C R INCNMT MEDICAL INCJOHN E AHERNRICHARD E DAVISBCRNMTINewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B1826496ccbn/B1826496norm...Excluding purchased R&D primarily for Edwards LifeStent deal, income and diluted EPS from continuing ops were $###.#m and $#.##, up #% and ##%, respectively over #Q##. ... 4/24/2008 12:11:00 AMC.R. Bard, Inc.54.0000EditedQ1 2008 C.R. Bard, Inc. Earnings Conference Call SummaryBCR5:00pm ETBriefB1826496Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1826496ccbn/T1826496norm...management believes provide an additional and meaningful assessment of the core operating performance of the Company and its individual product franchises. Reconciliations of non-GAAP measures to the most comparable GAAP measures are provided in Bard's earnings press release and in the Company's web site at www.crbard.com. All information that is not historical is given only as of April ##, ####, and the Company undertakes no responsibility to update any information. Unless otherwise noted, all comparisons are to the prior-year period. At this time, I will turn the call over to Mr. Timothy Ring. Please go ahead. ... 4/23/2008 7:11:00 PMC.R. Bard, Inc.54.0000FinalQ1 2008 C.R. Bard, Inc. Earnings Conference Call TranscriptBCR5:00pm ETTranscriptT1826496Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-24731366newstex/BW-0001-24731366xml MURRAY HILL, N.J., Apr. ##, #### (Business Wire) -- C. R. Bard, Inc. (NYSE: BCR) today reported #### first quarter financial results. First quarter #### net sales were $###.# million, an increase of ## percent over the prior-year period....04000000040160000401604804016018040160010401600304009000040090024/23/2008 5:05:35 PM180000001800800018004000180100001802300018020000Business WireBW-0001-24731366BARD C R INCTIMOTHY M RINGBCRNewsNewstexhttp://www.alacrastore.com/storecontent/spcred/644118spcred/644118normThe latest Full Report from S&Pglobal4/22/2008 1:07:36 PM400Full Report644118United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareFull ReportSolid position across several business segments; Strong cash flow; and Modest debt burden. Potential competitive pressures from larger companies with greater financial capacity; and Possible shifts in technology. The investment-grade rating on Murray Hill, N.J.-based C.R. Bard Inc. reflects the medical device manufacturer's solid position across several business segments, its strong cash flow, and its moderate debt burden. However, the rating also takes into account competitive pressures from larger companies with greater financial capacity and the risks associated with possible shifts in technology. Bard holds solid market-share positions across oncology, surgical, urology, and vascular product markets, with a particular strength in urology catheters and specialty access products. The company derives the majority of its revenues from products for which itUSA06738L06738M06738P06738335101010 351010 3510 35Bard (C.R.) Inc.108003USABCRFULLGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/644120spcred/644120normThe latest Summary from S&Pglobal4/22/2008 1:07:36 PM175Summary644120United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareSummaryThe investment-grade rating on Murray Hill, N.J.-based C.R. Bard Inc. reflects the medical device manufacturer's solid position across several business segments, its strong cash flow, and its moderate debt burden. However, the rating also takes into account competitive pressures from larger companies with greater financial capacity and the risks associated with possible shifts in technology. Bard holds solid market-share positions across oncology, surgical, urology, and vascular product markets, with a particular strength in urology catheters and specialty access products. The company derives the majority of its revenues from products for which it has a No. 1 or No. 2 market share, and it is not overly reliant on any particular device. New product development is a key to success, becauseUSA06738L06738M06738P06738335101010 351010 3510 35Bard (C.R.) Inc.108003USABCRSUMMARYGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/newstex/BW-0001-24679411newstex/BW-0001-24679411xml PENNINGTON, N.J., Apr. ##, #### (Business Wire) -- Weequahic Partners, LLC today announced that it plans to oppose the recently announced sale of Specialized Health Products International, Inc. to C.R. Bard, Inc. and will vote its #.#...0900000009015000040000000401600004016047040160084/22/2008 9:08:03 AM18000000180120001802000018007000Business WireBW-0001-24679411BARD C R INCSPECIALIZED HEALTH PRODUCTS INTERNATIONAL INCBCRSHPINewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-24520000newstex/BW-0001-24520000xml MURRAY HILL, N.J., Apr. ##, #### (Business Wire) -- C. R. Bard, Inc. (NYSE: BCR) today announced that it will host a conference call on Wednesday, April ##, #### at #:## PM EDT, to discuss the company's operating results for the first...040000000401600004016048040160184/15/2008 3:05:32 PM180000001800400018008000Business WireBW-0001-24520000BARD C R INCMICROSOFT CORPBCRMSFTNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-24309992newstex/PRN-0005-24309992xml ST. LOUIS, April #, ####, Apr. #, #### (PR Newswire delivered by Newstex) -- ST. LOUIS, April #, #### /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS), announced today that it has made two strategic additions to its senior...04000000040160000700000007010000090000000901500005000000050020000401000004010001040060000400600507014000070140091300000013001000130010021800000018007000190000001900200019002007PR Newswire US4/7/2008 8:08:28 AMPRN-0005-24309992BARD C R INCSTEREOTAXIS, INC.Bevil J HoggKEVIN T SHIFRINMICHAEL P KAMINSKIBCRSTXSNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B1744131ccbn/B1744131normQ# #### C.R. Bard, Inc. Earnings Conference Call1/31/2008 10:13:00 PMC.R. Bard, Inc.54.0000EditedQ4 2007 C.R. Bard, Inc. Earnings Conference Call SummaryBCR5:00pm ETBriefB1744131Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1744131ccbn/T1744131normQ# #### C.R. Bard, Inc. Earnings Conference Call1/31/2008 6:13:00 PMC.R. Bard, Inc.54.0000FinalQ4 2007 C.R. Bard, Inc. Earnings Conference Call TranscriptBCR5:00pm ETTranscriptT1744131Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/moodys/COP_600019916moodys/COP_600019916htmlGlobal Credit Research Credit Opinion # JUN #### Credit Opinion: C.R. Bard, Inc. C.R. Bard, Inc. Murray Hill, New Jersey, United States Ratings Category Moody's Rating Outlook Rating(s) Under Review Senior Unsecured *Baa# Commercial...1/3/2008 3:32:00 PMhtmlC.R. Bard, Inc.C.R. Bard, Inc.600019916150.0000NewsCredit OpinionCOP_600019916Credit & Investment ResearchMoody's Global Credit Researchhttp://www.alacrastore.com/storecontent/spcred/613196spcred/613196normThe latest Summary from S&P11/14/2007 1:22:02 PMSummary175global613196United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareSummaryThe investment-grade rating on Murray Hill, N.J.-based C.R. Bard Inc. reflects the medical device manufacturer's solid position across several business segments, its strong cash flow, and its moderate debt burden. However, the rating also takes into account competitive pressures from larger companies with greater financial capacity and the risks associated with possible shifts in technology. Bard holds solid market-share positions across oncology, surgical, urology, and vascular product markets, with a particular strength in urology catheters and specialty access products. The company derives almost 80% of its revenues from products for which it has a No. 1 or No. 2 market share, and it is not overly reliant on any particular device. New product development is a key to success, becauseUSA06738L06738M06738P06738335101010 351010 3510 35Bard (C.R.) Inc.108003USABCRSUMMARYGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/ccbn/B1670008ccbn/B1670008norm10/23/2007 9:12:00 PMC.R. Bard, Inc.54.0000EditedQ3 2007 C.R. Bard, Inc. Earnings Conference Call SummaryBCR5:00pm ET...Increase of ##% on an as reported basis and #% on a constant currency basis over #Q##, in line with guidance.... BriefB1670008Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1670008ccbn/T1670008norm10/23/2007 6:12:00 PMC.R. Bard, Inc.54.0000FinalQ3 2007 C.R. Bard, Inc. Earnings Conference Call TranscriptBCR5:00pm ET... - C.R. Bard, Inc, - Chairman, CEO Thank you. Good afternoon, everybody, and welcome to Bard's third quarter #### earnings conference call. I would like to again thank you for taking the time to join us today and I would expect the presentation portion of this call to last around ## minutes. The agenda today will go as follows; I'll begin a brief overview of the results of the third quarter for ####. John Weiland, our President and Chief Operating Officer will review third quarter product line revenue. Todd Schermerhorn, our Senior VP, and CFO, will review the third quarter income statement and balance sheet as well as our expectations for the third quarter. And after that John DeFord, our Senior VP of Science, Technology and Clinical Affairs, will give you an update of our product line development. Then we will do what we typically do, we will close with a Q & A. Third quarter, #### net sales totaled $###.# million. This represents an increase over the third quarter of last year of ##%... TranscriptT1670008Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1601728ccbn/B1601728norm7/24/2007 10:12:00 PMC.R. Bard, Inc.54.0000EditedQ2 2007 C.R. Bard, Inc. Earnings Conference Call SummaryBCR5:00pm ET...BCR reported #Q## net sales of $###.#m, income from continuing operations of $##m and diluted EPS of $#.##. For #Q## income from continuing operations is expected to be $#.##-#.##. ... BriefB1601728Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1601728ccbn/T1601728norm7/24/2007 7:14:00 PMC.R. Bard, Inc.54.0000FinalQ2 2007 C.R. Bard, Inc. Earnings Conference Call TranscriptBCR5:00pm ET...and other non-GAAP measures during this call. Management believes that when discussing revenue growth, eliminating the impact changes in foreign exchange, which have a nonoperating impact, provides an additional and meaningful assessment of the core health of individual product franchises. Reconciliations of non-GAAP measures to the most comparable GAAP measures are provided in Bard's earnings press release and on the Company's website at www.crbard.com. Please also note that all information that is not historical is given only as of July ##th, ####, and the Company undertakes no responsibility to update any information. Unless otherwise noted, all comparisons are to the prior year period. At this time, I would like to turn the call over to Mr. Timothy Ring. Please go ahead, sir. ... TranscriptT1601728Credit & Investment ResearchThomson Street Events